Alzheimer’s disease (AD) affects over 50 million people worldwide and is the most prevalent neurodegenerative disease in the world. The CDC reported that in 2014, 5 million people were living with AD in the United States. This number has been projected to rise to 14 million by 2050. AD is one of the top 10 leading causes of death in the United States; therefore, finding treatments and cures for these patients is crucial. Musical training has been observed to induce positive effects on brain development and plasticity, especially in regions of the medial temporal lobe. Providing a strong therapeutic approach in the improvement and restoration of neuroplasticity in the hippocampus, musical training holds the potential to alleviate neurological conditions in which the hippocampus is damaged, such as AD. Here the potential of musical training as a low-cost medium with no known negative side effects by which patients may alleviate neurodegenerative symptoms is reviewed.

‍